Vyome Holdings, Inc (HIND)
About Vyome Holdings, Inc
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $319.7K
- Net income
- -$10.3M
- Total assets
- $6.5M
- Market cap
- $15.2M
- Gross margin
- 68.4%
- Operating margin
- -3269.4%
- Net margin
- -3277.2%
Source: SEC EDGAR · updated Jun 7, 2026
Financial statements
Income statement
- Revenue
- $319.7K
- Cost of revenue
- $100.9K
- Gross profit
- $218.8K
- Operating expenses
- $10.7M
- Operating income
- -$10.5M
- Net income
- -$10.5M
- EPS (basic)
- $-4.86
- EPS (diluted)
- $-4.86
Balance sheet
- Total assets
- $6.5M
- Current assets
- $5.4M
- Total liabilities
- $2.7M
- Current liabilities
- $2.7M
- Shareholders’ equity
- $3.8M
Cash flow
- Operating cash flow
- -$3.7M
- Investing cash flow
- -$4.9M
- Financing cash flow
- $8.7M
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $15.2M
- EPS (diluted)
- $-4.86
- Shares outstanding
- 7.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 15, 2025
Vyome Holdings, Inc (HIND) Stock Price
- Reported a net loss of $10.3M in FY2025.
- Gross margin of 68.4%, net margin -3277.2%.
- Trading 85% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Vyome Holdings, Inc.
Write a review
Vyome Holdings, Inc: frequently asked questions
Is Vyome Holdings, Inc an American company?
Vyome Holdings, Inc is a US-based company headquartered in San Clemente, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Vyome Holdings, Inc headquartered?
Vyome Holdings, Inc is headquartered in San Clemente, California, United States.
Is Vyome Holdings, Inc publicly traded?
Yes — Vyome Holdings, Inc is a publicly traded company. Its stock trades under the ticker symbol HIND on the NASDAQ.
What does Vyome Holdings, Inc do?
Vyome Holdings, Inc is an American Pharmaceuticals company in the Health & Beauty sector.
